Home
News
Screeners
Insights
Centenial Surgical Suture
97.
05
0.00
(0.00%)
Market Cap
₹35.40 Cr
PE Ratio
-24.51
Industry
Healthcare
Buy
Sell
Company Performance:
1D
0.00%
1M
+18.28%
6M
+3.44%
1Y
-10.14%
5Y
0.00%
View Company Insights
Latest news about Centenial Surgical Suture
Centenial Surgical Suture schedules 31st AGM on September 28, 2026
Sep 01, 2026
Centenial Surgical Suture Ltd has scheduled its 31st e-AGM via video conferencing on September 28, 2026, at 2:00 pm. Members will vote on adoption of audited accounts for the year ended March 31, 2026. Re-appointment of Executive Director Anuradha Kashikar (DIN: 00804831) for three years from April 1, 2027 to March 31, 2030 with NIL remuneration is on the agenda. Remote e-voting opens September 24, 2026 at 9:00 am and closes September 27, 2026 at 5:00 pm; cut-off date is September 21, 2026. Anuradha Kashikar holds 6,98,500 equity shares and is the spouse of Managing Director Vijay Majrekar.
Centenial Surgical Suture Q1 Results: Net profit turns positive at ₹73.59 lakh
Aug 17, 2026
Centenial Surgical Suture Ltd Sanjay Sohani retires as President
Jun 24, 2026
Centenial Surgical Suture closes trading window ahead of Q1FY27 results
Jun 23, 2026
Centennial Surgical Suture reports net loss for FY26
Jun 03, 2026
More news about Centenial Surgical Suture
23
May 26
Centenial Surgical board meets on May 30 for FY26 results
Centenial Surgical Suture Ltd. will hold a board meeting on May 30, 2026, to approve standalone audited financial results for the quarter and year ended March 31, 2026. The meeting complies with SEBI (LODR) Regulations, 2015. The approved results will be disclosed on the BSE website after the meeting concludes.
16
Apr 26
Centenial Surgical Suture Ltd Submits Q4FY26 Compliance Certificate Under SEBI Depositories Regulations
Centenial Surgical Suture Ltd filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) with BSE Limited on April 16, 2026. The certificate, issued by registrar Purva Sharegistry (I) Private Limited, confirms proper processing of dematerialisation requests during the quarter ended March 31, 2026, with all securities handled within prescribed timelines and appropriate procedures followed for certificate cancellation and member register updates.
17
Mar 26
Centenial Surgical Suture Ltd Alleges Price Manipulation in Response to BSE Surveillance Inquiry
Centenial Surgical Suture Ltd responded to BSE surveillance inquiry dated March 13, 2026, alleging systematic price manipulation through suspicious small-lot transactions by investors across India. The company provided detailed trading data from January-March 2026 and requested comprehensive investigation, emphasizing no material announcements justified the price movements and confirming management has no involvement in the alleged activities.
17
Feb 26
Centenial Surgical Suture Files BSE Complaint Alleging Price Manipulation in Scrip 531308
Centenial Surgical Suture Ltd has filed a formal complaint with BSE alleging price manipulation in scrip 531308 during February 06-13, 2026. The company reported suspicious small-volume trading activities and requested investigation into potential SEBI regulation violations, while denying any involvement by company insiders in the alleged manipulative practices.
12
Feb 26
Centenial Surgical Suture Ltd. Board Approves Q3FY26 Financial Results
Centenial Surgical Suture Ltd. board approved standalone unaudited financial results for the quarter and nine months ended December 31, 2025, during a 20-minute meeting on February 12, 2026. The approval was conducted in compliance with Regulation 33 of SEBI (LODR) Regulations, 2015, with proper regulatory disclosure made to BSE Limited.
10
Oct 25
Centenial Surgical Suture Ltd Strengthens Audit Committee with New Appointment
Centenial Surgical Suture Ltd has appointed Neel Vora, an Independent Non-Executive Director, to its Audit Committee effective October 10, 2025. The appointment was made through a Circular Resolution passed by the Board of Directors. The reconstituted Audit Committee now comprises four members: Akash Modi (Chairman), Ridhima Limaye, Neel Vora, and Vijay Majrekar. This change aligns with the company's efforts to maintain high standards of financial oversight and transparency.
Centenial Surgical Suture
97.
05
0.0
(0.0%)
1 Year Returns:
-10.14%
Industry Peers
Poly Medicure
1,738.50
(-
0.
53
%)
Q-Line Biotech
726.20
(+
1.
57
%)
Tarsons Products
311.20
(-
2.
03
%)
Laxmi Dental
202.84
(+
0.
14
%)
Hemant Surgical Industries
470.00
(+
1.
85
%)
Vasa Denticity
390.00
(0.0%)
Osel Devices
372.15
(+
0.
13
%)
Fabtech Technologies
147.02
(-
0.
27
%)
Prevest Denpro
407.60
(+
4.
29
%)
Nureca
332.75
(-
3.
14
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar